Cello Health PLC – COVID-19 Update
Cello Health plc (AIM: CLL), the global healthcare-focused advisory group, today announces the following trading update in response to the potential impact of the COVID-19 virus on its business.
Read More
Cello Health PLC – Interim Results
Cello Health plc (AIM: CLL), the healthcare-focused advisory group, today announces its interim results for the six month period to 30 June 2019.
Cello Health PLC – Acquisition of ISS
Cello Health plc (AIM: CLL), the healthcare-led advisory group, is pleased to announce the acquisition of the trade and assets of Innovative Science Solutions, LLP.
Six AIM overseas earners boosted by weaker pound
Sterling has been weak since Boris Johnson became Prime Minister, but it was also languishing before that. Smaller companies tend to be viewed as dependent on the UK economy, and that is true of some AIM stocks, but there are plenty of examples of AIM companies that have thriving international businesses.
Cello Health PLC – Pre-close Trading Update
Cello Health plc (AIM: CLL), the global healthcare-focused advisory Group, today publishes the following trading update for the six months ended 30 June 2019.
Cello Health PLC – Preliminary Results
Cello Health plc (AIM:CLL), the healthcare-focused advisory group, today announces its results for the year to 31 December 2018.
Cello Health PLC – Pre-close Trading Update
Cello Health plc (AIM: CLL), the global healthcare-focused advisory Group, today publishes the following trading update for the six months to 30 June 2018.